Functional characterization of human and cynomolgus monkey UDP-glucuronosyltransferase 1A1 enzymes.
作者： Nobumitsu Hanioka , Natsuko Tanabe , Hideto Jinno , Toshiko Tanaka-Kagawa , Kenjiro Nagaoka
DOI: 10.1016/J.LFS.2010.07.001
关键词:
摘要: … were no significant differences in the levels of kinetic parameters for 7-HFC, E-3OH and SN-38 … Thus, there were no remarkable species differences in the kinetics of 7-HFC, E-3OH and …
elsevier.com
sci-hub.se 参考文章(34)
Ken-Ichi Fujita, Yasutsuna Sasaki, Yuichi Ando, Yoshinori Hasegawa, UGT1AI*6 and UGT1A1*27 for individualized irinotecan chemotherapy. Current Opinion in Molecular Therapeutics. ,vol. 9, pp. 258- 262 ,(2007)
Michael H. Court, Isoform‐Selective Probe Substrates for In Vitro Studies of Human UDP‐Glucuronosyltransferases Methods in Enzymology. ,vol. 400, pp. 104- 116 ,(2005) , 10.1016/S0076-6879(05)00007-8
A. Lewis Farr, Oliver H. Lowry, Rose J. Randall, Nira J. Rosebrough, Protein Measurement with the Folin Phenol Reagent Journal of Biological Chemistry. ,vol. 193, pp. 265- 275 ,(1951)
S B Senafi, D J Clarke, B Burchell, Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation Biochemical Journal. ,vol. 303, pp. 233- 240 ,(1994) , 10.1042/BJ3030233
Steven A. Wrighton, Kristina Campanale, Bradley L. Ackermann, Michael B. Fisher, Mark VandenBranden, In vitro glucuronidation using human liver microsomes and the pore-forming peptide alamethicin. Drug Metabolism and Disposition. ,vol. 28, pp. 560- 566 ,(2000)
Olivier Barbier, Alain Bélanger, The cynomolgus monkey (Macaca fascicularis) is the best animal model for the study of steroid glucuronidation. The Journal of Steroid Biochemistry and Molecular Biology. ,vol. 85, pp. 235- 245 ,(2003) , 10.1016/S0960-0760(03)00235-8
Yuichi Ando, Yoshinori Hasegawa, Clinical pharmacogenetics of irinotecan (CPT-11). Drug Metabolism Reviews. ,vol. 37, pp. 565- 574 ,(2005) , 10.1080/03602530500316254
T KIANG, M ENSOM, T CHANG, UDP-glucuronosyltransferases and clinical drug-drug interactions Pharmacology & Therapeutics. ,vol. 106, pp. 97- 132 ,(2005) , 10.1016/J.PHARMTHERA.2004.10.013
Shirley S. Brill, Anna M. Furimsky, Mark N. Ho, Michael J. Furniss, Yi Li, Adam G. Green, Carol E. Green, Lalitha V. Iyer, Wallace W. Bradford, Izet M. Kapetanovic, Glucuronidation of trans-resveratrol by human liver and intestinal microsomes and UGT isoforms. Journal of Pharmacy and Pharmacology. ,vol. 58, pp. 469- 479 ,(2010) , 10.1211/JPP.58.4.0006
Peter I. Mackenzie, Ida S. Owens, Brian Burchell, K W Bock, Amos Bairoch, Alain Belanger, Sylvie Fournel Gigleux, Mitchell Green, Dean W. Hum, Takashi Iyanagi, Doron Lancet, Pierre Louisot, Jacques Magdalou, Jayanta Roy Chowdhury, Joseph K. Ritter, Thomas R. Tephly, Harry Schachter, Thomas Tephly, Keith F Tipton, Daniel W. Nebert, The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics. ,vol. 7, pp. 255- 269 ,(1997) , 10.1097/00008571-199708000-00001